Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis

Area of Science:

• Neurology
• Immunology
• Pharmacology

Background:

• Multiple sclerosis (MS) is a significant neurological disorder impacting millions globally, primarily young adults.
• The last two decades have seen the introduction of over ten disease-modifying therapies (DMTs) for MS management.
• These DMTs vary in efficacy, administration, side effects, and pregnancy considerations.

Purpose of the Study:

• To provide an updated review on personalizing DMT selection for relapsing MS.
• To emphasize the importance of individualized treatment strategies in MS care.
• To advocate for shared decision-making in DMT use.

Main Methods:

• Review of current literature on DMTs for relapsing multiple sclerosis.
• Analysis of factors influencing DMT choice, including patient heterogeneity and treatment response.
• Synthesis of evidence supporting personalized medicine approaches.

Main Results:

• MS patients are clinically diverse, with varying disease severity, MRI lesion load, and DMT response.
• Appropriate DMT selection requires careful consideration of individual patient profiles and potential risks.
• Shared decision-making models enhance patient engagement and treatment adherence.

Conclusions:

• Personalized DMT selection is crucial for optimizing outcomes in relapsing MS.
• Shared decision-making, incorporating patient preferences and understanding of risks/benefits, is recommended.
• Tailoring DMTs to individual MS patients improves therapeutic efficacy and safety.